Your browser doesn't support javascript.
loading
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Iland, Harry J; Russell, Nigel; Dillon, Richard; Schuh, Andre C; Tedjaseputra, Aditya; Wei, Andrew; Khwaja, Asim; Knapper, Steven; Lane, Steven W; Reynolds, John; McMullin, Mary Frances; Martin, Annalise; Tan, Peter; Taussig, David C; Wong, Anny; Taper, John; Fraga, Christina; Kelly, Richard; Tawana, Kiran; Mehta, Priyanka; Mina, Alain; Altman, Jessica K; Mølle, Ingolf; Tauro, Sudhir; Tholouli, Eleni.
Affiliation
  • Iland HJ; Institute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, Australia.
  • Russell N; Department of Haematology, Guy's and St Thomas' Hospital, London, United Kingdom.
  • Dillon R; Department of Medical and Molecular Genetics, Kings College London, London, United Kingdom.
  • Schuh AC; Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
  • Tedjaseputra A; Department of Haematology, Alfred Hospital, Melbourne, Australia.
  • Wei A; Department of Haematology, Alfred Hospital, Melbourne, Australia.
  • Khwaja A; Department of Haematology, University College Hospital, London, United Kingdom.
  • Knapper S; Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Lane SW; Cancer Care Services, Royal Brisbane & Women's Hospital and University of Queensland, Brisbane, Australia.
  • Reynolds J; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
  • McMullin MF; School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
  • Martin A; Haematology Department, Royal Perth Hospital, Perth, Australia.
  • Tan P; Haematology Department, Royal Perth Hospital, Perth, Australia.
  • Taussig DC; Royal Marsden Hospital, London, United Kingdom.
  • Wong A; Department of Paediatric Oncology and Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Taper J; Department of Haematology, Nepean Hospital, Nepean, Australia.
  • Fraga C; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, Canada.
  • Kelly R; Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Tawana K; Department of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom.
  • Mehta P; Bristol Haematology and Oncology Centre, University Hospitals of Bristol and Weston NHS Trusts, Bristol, United Kingdom.
  • Mina A; Division of Bone Marrow Transplant and Cellular Therapies, Department of Medicine, Stanford University, Stanford, CA.
  • Altman JK; Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Mølle I; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Tauro S; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, United Kingdom.
  • Tholouli E; Department of Adult Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.
Blood Adv ; 7(11): 2580-2585, 2023 06 13.
Article in En | MEDLINE | ID: mdl-36075018
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Affiliation country: Australia